Clinical trial Recruiting at 1 site Interventional Ages 18 to 65

Comparing dexmedetomidine and bupivacaine for pain management after brain surgery

Official title: Dexmedetomidine as an Adjuvant to Bupivacaine in Scalp Block Versus Bupivacaine Alone for Postoperative Pain Management in Patients Undergoing Craniotomy

Run by Ain Shams University · NCT06993922 · Data updated 2026-11-12

This study is testing if adding dexmedetomidine to bupivacaine can help reduce pain better after brain surgery compared to using bupivacaine alone.

More Postoperative Pain trials

Quick facts

Study typeInterventional
Ages18 Years to 65 Years
SexAll
Enrollment50 (estimated)
SponsorAin Shams University
Academic / other
Locations1 site (Cairo)
StatusRecruiting
StartedMay 29, 2025
Main results expectedNovember 1, 2025
Study endsNovember 1, 2025
Registry record updatedMay 30, 2025
Trial IDNCT06993922 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults aged 18 to 65 years undergoing elective supratentorial craniotomies with ASA physical status I or II.

Probably not a fit

Patients with a history of allergy to the study medications, bleeding disorders, or those requiring emergency craniotomy may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study compares the effectiveness of dexmedetomidine as an adjuvant to bupivacaine in scalp block versus bupivacaine alone for managing postoperative pain in patients undergoing craniotomy. The approach utilizes scalp block as a multimodal strategy to alleviate pain and reduce hemodynamic responses during surgery. By incorporating dexmedetomidine, a selective alpha-2 adrenergic receptor agonist, the study aims to enhance the analgesic effects and prolong the duration of action of local anesthetics.

Why it matters

Potential benefit: If successful, this approach could significantly improve postoperative pain management for patients undergoing craniotomy.

How similar studies have gone: Previous studies have shown promising results with the use of dexmedetomidine as an adjuvant in pain management, indicating potential success for this approach.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Age from 18 to 65 years.
* Both sexes.
* American Society of Anesthesiologists (ASA) physical status I or II.
* Undergoing supratentorial elective planned craniotomies.

Exclusion Criteria:

* Patients refusal.
* History of known allergy to the used local anesthetic or dexmedetomidine.
* Bleeding disorders.
* Evidence of local infection at the site of injection.
* Emergency craniotomy.
* Psychotic disorder.
* Patients who will not be extubated in the operating room after surgery.

Where it's running

  • Ain Shams University
    Cairo, Egypt
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.